Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
2.
Iatreia ; 3(1): 7-12, mar. 1990. tab
Article in Spanish | LILACS | ID: lil-84086

ABSTRACT

Aunque se ha investigado extensamente el significado clinico de los anticuerpos antinuecleares (ANA) y se han reconocido algunas correlaciones, no esta establecido el valor diagnostico del patron mixto de ANA y anticitoplasmaticos (ANA + ACA). Nosotros observamos dicho patron mixto en el suero de 43 pacientes de un total de 7.121 examinados (0.6%). La combinacion mas comun fue con el patron homogeneo de ANA. Las entidades asociadas al patron mixto son basicamente las mismas que se asocian con los diferentes ANA; el Lupus Eritematoso Sistemico (LES) es la mas frecuente. Concluimos que la informacion obtenida del hallazgo de un patron combinado ANA + ACA es la misma que se obtiene con los ANA positivos y que su presencia en pacientes con LES no caracteriza a ningun subgrupo de la enfermedad en particular


To date, the clinical significance of combined antinuclear (ANA) and anti-cytoplasmic (ACA) indirect immunofluorescent staining has not been comprehensively studied. ANA + ACA staining was observed in 43 (0.6%) out of 7.121 consecutive sera during ANA screening for immunologic disorders in a referral hospital; both inpatient and outpatient population were included. Homogeneous ANA + cytoplasmic was by far the most common staining pattern among 6 different fluorescent combinations detected. Disease distribution was similar in groups of patients with ANA + ACA and in those with only ANA +. We conclude that information provided by mixed antibody pattern is similar to the one obtained with the sole presence of ANA; also that the presence of the mixed pattern does not characterize any particular subgroup of LES patiens.


Subject(s)
Humans , Male , Female , Adult , Autoantibodies/immunology , Antibodies, Antinuclear/immunology , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/epidemiology , Antibodies, Antinuclear/physiology , Fluorescent Antibody Technique , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL